Literature DB >> 27396447

A guide to immunometabolism for immunologists.

Luke A J O'Neill1, Rigel J Kishton2, Jeff Rathmell2.   

Abstract

In recent years a substantial number of findings have been made in the area of immunometabolism, by which we mean the changes in intracellular metabolic pathways in immune cells that alter their function. Here, we provide a brief refresher course on six of the major metabolic pathways involved (specifically, glycolysis, the tricarboxylic acid (TCA) cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism), giving specific examples of how precise changes in the metabolites of these pathways shape the immune cell response. What is emerging is a complex interplay between metabolic reprogramming and immunity, which is providing an extra dimension to our understanding of the immune system in health and disease.

Entities:  

Mesh:

Year:  2016        PMID: 27396447      PMCID: PMC5001910          DOI: 10.1038/nri.2016.70

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  99 in total

1.  Glutamine is essential for nitric oxide synthesis by murine macrophages.

Authors:  C F Bellows; B M Jaffe
Journal:  J Surg Res       Date:  1999-10       Impact factor: 2.192

2.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

5.  Macrophages, lipid oxidation, ceroid accumulation and alpha-tocopherol depletion in human atherosclerotic lesions.

Authors:  K L Carpenter; C van der Veen; S E Taylor; S J Hardwick; K Clare; L Hegyi; M J Mitchinson
Journal:  Gerontology       Date:  1995       Impact factor: 5.140

6.  Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages.

Authors:  P Newsholme; R Curi; S Gordon; E A Newsholme
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

8.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

9.  Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.

Authors:  Stefan Freigang; Franziska Ampenberger; Adrienne Weiss; Thirumala-Devi Kanneganti; Yoichiro Iwakura; Martin Hersberger; Manfred Kopf
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

10.  Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Authors:  John T Pesce; Thirumalai R Ramalingam; Margaret M Mentink-Kane; Mark S Wilson; Karim C El Kasmi; Amber M Smith; Robert W Thompson; Allen W Cheever; Peter J Murray; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more
  821 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

2.  Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

Authors:  Gael F P Bories; Scott Yeudall; Vlad Serbulea; Todd E Fox; Brant E Isakson; Norbert Leitinger
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

3.  Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion.

Authors:  Julie Charpentier; Francois Briand; Benjamin Lelouvier; Florence Servant; Vincent Azalbert; Anthony Puel; Jeffrey E Christensen; Aurélie Waget; Maxime Branchereau; Céline Garret; Jérome Lluch; Christophe Heymes; Emmanuel Brousseau; Rémy Burcelin; Laurence Guzylack; Thierry Sulpice; Estelle Grasset
Journal:  Acta Diabetol       Date:  2021-03-15       Impact factor: 4.280

4.  Deamidation Shunts RelA from Mediating Inflammation to Aerobic Glycolysis.

Authors:  Jun Zhao; Mao Tian; Shu Zhang; Alireza Delfarah; Ruoyun Gao; Youliang Rao; Ali Can Savas; Anjie Lu; Larissa Bubb; Xiao Lei; Rosa Moshirian; Wenjie Zhu; Cheng Peng; Taijiao Jiang; Lin Chen; Nicholas A Graham; Pinghui Feng
Journal:  Cell Metab       Date:  2020-04-22       Impact factor: 27.287

Review 5.  Beyond BMI: Obesity and Lung Disease.

Authors:  Ubong Peters; Benjamin T Suratt; Jason H T Bates; Anne E Dixon
Journal:  Chest       Date:  2017-07-17       Impact factor: 9.410

6.  Metabolic pathways and immunometabolism in rare kidney diseases.

Authors:  Peter C Grayson; Sean Eddy; Jaclyn N Taroni; Yaíma L Lightfoot; Laura Mariani; Hemang Parikh; Maja T Lindenmeyer; Wenjun Ju; Casey S Greene; Brad Godfrey; Clemens D Cohen; Jeffrey Krischer; Matthias Kretzler; Peter A Merkel
Journal:  Ann Rheum Dis       Date:  2018-05-03       Impact factor: 19.103

Review 7.  Disentangling the role of neutrophil extracellular traps in rheumatic diseases.

Authors:  Yaíma L Lightfoot; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-01       Impact factor: 5.006

Review 8.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

9.  TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization.

Authors:  Ting-Ting Feng; Xiao-Ying Yang; Shan-Shan Hao; Fen-Fen Sun; Ye Huang; Qi-Si Lin; Wei Pan
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

Review 10.  Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.

Authors:  Barry E Kennedy; Maryanne Sadek; Shashi A Gujar
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.